NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NEI E-050-2015-0-DE-16 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa DE EP 20176667.2 Issued
NEI E-050-2015-0-IT-15 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa IT EP 20176667.2 Issued
NEI E-050-2015-0-FR-14 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa FR EP 20176667.2 Issued
NCI E-028-2015-1-AU-36 ANTI-MUTATED KRAS T CELL RECEPTORS AU DIV 2020203465 Issued
NIAID E-080-2013-0-AU-08 Attenuation of Human Respiratory Syncytial Virus by Genome Scale Codon-Pair Deoptimization AU DIV 2020203460 Issued
NICHD E-003-2018-1-US-02 AUTOPHAGY MODULATORS FOR USE IN TREATING CANCER US CIP 16/883,046 11471460 Issued PDF
NCI E-495-2013-0-HK-20 Anti-Human Papillomavirus 16 E6 T Cell Receptors HK EP 42020008016.6 Issued
NCI E-016-2018-0-KR-05 CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS KR National Stage 10-2020-7014565 Pending
NIAID E-076-2019-0-PCT-02 MAMMALIAN CELL FOR PRODUCING MODIFIED VACCINIA ANKARA (MVA) VIRUS PCT PCT PCT/US2020/033788 Expired
NCI E-042-2014-0-NZ-18 Chimeric Antigen Receptors Targeting CD-19 NZ DIV 764530 Issued
NIAMS E-024-2018-0-US-06 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING AND/OR PREVENTING PERIODONTAL DISEASE US National Stage 16/765,420 Abandoned
NIAID E-198-2025-0-US-03 VIRAL SEROLOGY ASSAYS US 63/027,234 Expired
NCATS E-026-2016-0-US-19 Compounds for Improving mRNA Splicing US CON 16/877,254 11702417 Issued PDF
NIAID E-241-2014-0-US-08 RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 1 (HPIV1) EXPRESSING A CHIMERIC RSV/HPIV1 F PROTEIN AND USES THEREOF US CON 16/877,319 11591372 Issued PDF
NIAID E-216-2014-0-US-15 RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS STRAINS WITH MUTATIONS IN THE M2-2 ORF PROVIDING A RANGE OF ATTENUATION PHENOTYPES US CON 16/877,277 11332721 Issued PDF
CC E-128-2020-0-US-01 ISOLATION DEVICES TO REDUCE CONTAMINATION DURING IMAGING OF PATIENTS US 63/026,502 Abandoned
NCI E-029-2022-0-US-01 Compositions And Methods For Prevention Of Coronavirus Infection US 63/026,375 Abandoned
NCATS E-035-2020-1-US-01 TREATING PRIMARY OR IDIOPATHIC HYPEROXALURIA WITH SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE US 63/026,296 Expired
NCI E-094-2017-0-JP-08 Fully Human Antibody Binders To Human Mesothelin For CAR-T Therapeutics Treatment JP DIV 2020-085861 Issued
NIAID E-182-2020-5-US-01 CORONAVIRUS RNA VACCINES AND METHODS OF USE US 63/025,918 Abandoned
NIAID E-128-2021-0-US-01 COMPOSITIONS, SYSTEMS, AND METHODS FOR GENERATING GENE-EDITED CELLS US 63/025,815 Abandoned
NIMH E-142-2020-0-US-01 SYSTEMS AND METHODS FOR MEASURING INTERVENTION OUTCOMES USING MOOD MACHINE INTERFACE US 63/025,776 Abandoned
NIAID E-198-2025-0-US-02 VIRAL SEROLOGY ASSAYS US 63/025,609 Expired
NCI E-085-2013-0-CN-26 Methods for Producing Enriched Populations of Tumor Reactive T Cells from Peripheral Blood CN DIV 202010410564.8 Issued
NIAID E-104-2020-0-US-01 RSV VACCINE BEARING ONE OR MORE P GENE MUTATIONS US 63/023,949 Abandoned
NIAID E-145-2021-0-US-01 Adjuvanted Stabilized Stem Hemagglutinin Nanoparticles And Methods Of Using The Same To Induce Broadly Neutralizing Antibodies Against Influenza US 63/023,978 Abandoned
CC E-028-2017-0-US-03 DEVICES WITH LOW MELTING POINT ALLOY FOR CONTROL OF DEVICE FLEXIBILITY US DIV 16/872,519 11931893 Issued PDF
NHLBI E-186-2014-1-US-15 SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 US CON 15/930,057 11384131 Issued PDF
NIMH E-174-2006-0-US-16 Intranasal Administration Of Ketamine To Treat Depression US CON 15/930,140 Abandoned
NIDA E-005-2018-1-US-02 ATYPICAL INHIBITORS OF MONOAMINE TRANSPORTERS; METHOD OF MAKING; AND USE THEREOF US National Stage 16/762,998 11365195 Issued PDF
NCATS E-157-2020-1-US-01 METHODS OF TREATING CORONAVIRUS INFECTIONS US 63/023,133 Abandoned
NCI E-495-2013-0-HK-21 Anti-Human Papillomavirus 16 E6 T Cell Receptors HK CN 42020007152.0 Issued
NCI E-291-2012-0-US-24 M971 CHIMERIC ANTIGEN RECEPTORS US DIV 16/869,792 11807682 Issued PDF
NIAAA E-282-2012-0-US-11 CANNABINOID RECEPTOR MEDIATING COMPOUNDS US DIV 16/870,093 11485709 Issued PDF
NIAID E-078-2021-0-US-01 Nanoparticle Vaccines For Coronaviruses US 63/022,214 Abandoned
NIAID E-251-2020-0-US-01 PPMO Targeting SARS-CoV-2 Genomic RNA To Treat And Prevent Coronavirus Infection US 63/021,859 Abandoned
NCI E-132-2017-0-US-03 METHODS OF PREPARING HEMATOPOIETIC PROGENITOR CELLS IN VITRO US National Stage 16/762,447 12037607 Issued PDF
NCI E-016-2018-0-US-06 CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 OR MESOTHELIN US National Stage 16/762,459 11802163 Issued PDF
NCI E-167-2017-0-EP-06 CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY EP National Stage 18819232.2 Pending
NCI E-167-2017-0-JP-07 NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY JP National Stage 2020-524774 Abandoned
NIAMS E-024-2018-0-IL-05 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING AND/OR PREVENTING PERIODONTAL DISEASE IL National Stage 274529 Abandoned
NHGRI E-054-2020-0-US-01 ABERRANT POST-TRANSLATIONAL MODIFICATIONS (PTMS) IN METHYL- AND PROPIONIC ACIDEMIA AND A MUTANT SIRTUIN (SIRT) TO METABOLIZE PTMS US 63/021,179 Abandoned
NCI E-064-2019-0-PCT-02 CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 PCT PCT PCT/US2020/031729 Expired
NCI E-064-2019-0-EP-01 CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 EP National Stage 20802725.0 Pending
NCI E-064-2019-0-CA-03 Fully Human Antibodies Targeting Human GPC2 For Therapeutics Development CA National Stage 3139507 Pending
NCI E-182-2017-0-DE-01 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION DE EP 18786145.5 Issued
NCI E-182-2017-0-FR-01 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION FR EP 18786145.5 Issued
NCI E-182-2017-0-FI-01 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION FI EP 18786145.5 Issued
NCI E-182-2017-0-IT-01 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION IT EP 18786145.5 Issued
NCI E-182-2017-0-NO-01 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION NO EP 18786145.5 Issued